Application
Dot blot analysis of Phospho-MYH9-Y158 Antibody Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6ug per ml.| Product Name | MYH9 (Y158) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MYH9; Myosin-9; Cellular myosin heavy chain, type A; Myosin heavy chain 9; Myosin heavy chain, non-muscle IIa; Non-muscle myosin heavy chain A; Non-muscle myosin heavy chain IIa |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | DB |
| DB:1:500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | MYH9 Myosin-9 Cellular myosin heavy chain type A Myosin heavy chain 9 Myosin heavy chain non-muscle IIa Non-muscle myosin heavy chain A Non-muscle myosin heavy chain IIa |
|---|---|
| Molecular Weight(MW) | 226532 Da |
| Function | Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping |
| Tissue Specificity | In the kidney, expressed in the glomeruli. Also expressed in leukocytes |
| Cellular Localization | Cytoplasm, cytoskeleton (By similarity). Cytoplasm, cell cortex (By similarity). Note=Colocalizes with actin filaments at lamellipodia margins and at the leading edge of migrating cells (By similarity) |
| Entrez Gene | 4627 |
|---|---|
| Nucleotide Accession | NP_002464.1 |
Application
Dot blot analysis of Phospho-MYH9-Y158 Antibody Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.6ug per ml.| Application Notes | DB:1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification. |
